Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyoko Yamada

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Liver Cancer|August 8, 2024
Impact of Bevacizumab Being Skipped due to Adverse Events of Special Interest for Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab: An Exploratory Analysis of the Phase III IMbrave150 StudyMasatoshi Kudo, Kaoru Tsuchiya, Yu-Yun Shao, et al.
Frontiers in Immunology|May 13, 2026
N-terminal pyroglutamylation of an HLA-A24-restricted immunodominant epitope enhances SARS-CoV-2-specific T-cell responsesYoshiki Aritsu, Masahiro Kitabatake, Amiri Kurose, et al.
BMC Gastroenterology|September 15, 2014
Successful management of severe intrahepatic cholestasis of pregnancy: report of a first Japanese caseKenya Kamimura, Hiroyuki Abe, Naomi Kamimura, et al.
The Journal of Clinical Investigation|August 17, 2021
A sublethal ATP11A mutation associated with neurological deterioration causes aberrant phosphatidylcholine flipping in plasma membranesKatsumori Segawa, Atsuo Kikuchi, Tomoyasu Noji, et al.
Vaccine|March 10, 2005
The development of vaccines against SARS corona virus in mice and SCID-PBL/hu miceMasaji Okada, Yuji Takemoto, Yoshinobu Okuno, et al.
Advances in Experimental Medicine and Biology|October 14, 2006
Development of vaccines and passive immunotherapy against SARS coronavirus using mouse and SCID-PBL/hu mouse modelsMasaji Okada, Yuji Takemoto, Yoshinobu Okuno, et al.
Vaccine|March 10, 2005
Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey modelYoko Kita, Takao Tanaka, Shigeto Yoshida, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Liver Cancer|August 8, 2024
Impact of Bevacizumab Being Skipped due to Adverse Events of Special Interest for Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab: An Exploratory Analysis of the Phase III IMbrave150 StudyMasatoshi Kudo, Kaoru Tsuchiya, Yu-Yun Shao, et al.
Frontiers in Immunology|May 13, 2026
N-terminal pyroglutamylation of an HLA-A24-restricted immunodominant epitope enhances SARS-CoV-2-specific T-cell responsesYoshiki Aritsu, Masahiro Kitabatake, Amiri Kurose, et al.
BMC Gastroenterology|September 15, 2014
Successful management of severe intrahepatic cholestasis of pregnancy: report of a first Japanese caseKenya Kamimura, Hiroyuki Abe, Naomi Kamimura, et al.
The Journal of Clinical Investigation|August 17, 2021
A sublethal ATP11A mutation associated with neurological deterioration causes aberrant phosphatidylcholine flipping in plasma membranesKatsumori Segawa, Atsuo Kikuchi, Tomoyasu Noji, et al.
Vaccine|March 10, 2005
The development of vaccines against SARS corona virus in mice and SCID-PBL/hu miceMasaji Okada, Yuji Takemoto, Yoshinobu Okuno, et al.
Advances in Experimental Medicine and Biology|October 14, 2006
Development of vaccines and passive immunotherapy against SARS coronavirus using mouse and SCID-PBL/hu mouse modelsMasaji Okada, Yuji Takemoto, Yoshinobu Okuno, et al.
Vaccine|March 10, 2005
Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey modelYoko Kita, Takao Tanaka, Shigeto Yoshida, et al.
Pageof 6